GHUCCTS

GHUCCTS

Discovery through Diversity

GHUCCTS designs and implements research that will have a high impact on underserved groups in our communities, including people from diverse racial, ethnic, and cultural backgrounds, people with disabilities, and older adults.

Learn More

Responses to COVID-19

As the COVID-19 pandemic continues to evolve in the greater Washington DC area, we are following the directives of our respective universities and institutions. As a result, most GHUCCTS physical offices are closed and we have shifted to virtual support for our research faculty, staff and trainees. Our Clinical Research Units at Georgetown University Hospital and Howard University Hospital remain open for ongoing studies that require scheduled visits for already enrolled patients, but not for new enrollments or new protocols at this time.

Read More

Upcoming Events
Jan 21
The Georgetown University Medical Center (GUMC) Office of the Dean for Research is proud to present the Dean's Seminar Series. This seminar features Peter Tontonoz, MD, PhD, Professor, Pathology & Laboratory Medicine, UCLA Health. Dr. Tontonoz will discuss "New Pathways for Cellular and Systemic Lipid Transport".
This Windows into Translation (WiT) seminar features Jeffrey K. Huang, PhD, Associate Professor in the Department of Biology at the Georgetown University Medical Center. Dr. Huang is also the Deputy Director for the Center for Cell Reprogramming. Dr. Riesenhuber will discuss " Myelin regeneration in multiple sclerosis (MS)".
Jan 22
This month's MHRI-GHUCCTS Monthly Statistical Seminar Series features Dr. Paul Kolm, Associate Director in the Department of Biostatistics and Biomedical Informatics at MedStar Health Research Institute. Dr. Kolm will discuss meta-analysis. Meta-analysis combines the results of several studies to overcome small samples of individual studies and estimate a "true" effect size of some treatment, therapy, etc. There has been a substantial increase in the number of meta-analyses published in the past few years, but many appear to not understand the potential problems of the method and draw incorrect conclusions. We will examine the method, potential problems, and what can and cannot be inferred from the results.
This Duke Clinical Research Institute (DCRI) NIH "Rethinking Clinical Trials" Grand Rounds features Harlan M. Krumholz, MD, SM, Harold H. Hines, Jr. Professor of Medicine and Public Health at Yale University, and Joseph S. Ross, MD, MHS, Professor of Medicine and Public Health at Yale University. Drs. Krumholz and Ross will discuss " Is It Time to Embrace Preprints? A Conversation About the First 18 Months of medRxiv".
Related News

Deadline Extended: 2021 KL2 Scholars Program Application

Jan 05, 2021

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is now accepting applications for our 2021 KL2 Scholars Program. The pre-application is due January 31, 2021 with the final application due February 28, 2021. Funding is expected to begin in June 2021 pending the evolution of the COVID-19 pandemic.

Two GHUCCTS advisors named to NIH ACTIV-1 Community Advisory Board

Dec 17, 2020

We are proud to share that two of our advisors have been named to the Community Advisory Board (CAB) for the National Institutes of Health Accelerating COVID-19 Therapeutics Interventions and Vaccines (ACTIV) initiative. Robert Pearson, a member of our Participant Advisory Board (PAB), and Larisa Caicedo, a member of our own CAB, will advise on the ACTIV-1 protocol.

NHCOA honors Florencia Gonzalez with Research Recognition Award

Dec 11, 2020

On Tuesday December 15, 2020, the National Hispanic Council on Aging (NHCOA) will honor Florencia Gonzalez as a 2020 recipient of the NHCOA Award. The virtual ceremony, called A Time for Change, will recognize leaders in the field of aging who share NHCOA’s commitment to Hispanic older adults.

Close